Wikidata |

Wikidata

Matches in Wikidata for { <http://www.wikidata.org/entity/Q81416970> ?p ?o ?g. }

Showing items 1 to 100 of ±114 with 100 items per page.

Q81416970 description "artículu científicu espublizáu en mayu de 2005" @default.
Q81416970 description "im Mai 2005 veröffentlichter wissenschaftlicher Artikel" @default.
Q81416970 description "scientific article published on 01 May 2005" @default.
Q81416970 description "wetenschappelijk artikel" @default.
Q81416970 description "наукова стаття, опублікована в травні 2005" @default.
Q81416970 name "Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies" @default.
Q81416970 name "Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies" @default.
Q81416970 type Item @default.
Q81416970 label "Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies" @default.
Q81416970 label "Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies" @default.
Q81416970 prefLabel "Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies" @default.
Q81416970 prefLabel "Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies" @default.
Q81416970 P1433 Q81416970-D0859399-918A-4B42-B457-2406D0E08BEB @default.
Q81416970 P1476 Q81416970-15D07539-E68D-4388-8B29-3D72299F3473 @default.
Q81416970 P2093 Q81416970-10CD06C0-ED1D-47A3-BC53-78176D317368 @default.
Q81416970 P2093 Q81416970-3029D913-0A1C-4D1E-BE6F-AB4691F10B65 @default.
Q81416970 P2093 Q81416970-4DC4B7CA-EE70-4372-A011-3696774C7309 @default.
Q81416970 P2093 Q81416970-62A4CABC-CF2B-454E-AC27-CBD3F614C4DB @default.
Q81416970 P2093 Q81416970-8048519B-E0E6-4372-9977-6DDEBA595304 @default.
Q81416970 P2093 Q81416970-9D7ECC1E-A3A4-4CDF-9BA8-AF264C432279 @default.
Q81416970 P2093 Q81416970-C99D4E95-5FD3-4421-911F-68EFF7B14EE2 @default.
Q81416970 P2093 Q81416970-CE5A50DF-E061-483B-BA35-5042CD600802 @default.
Q81416970 P2093 Q81416970-D3CA0E69-7836-4591-83CE-718F49D0960A @default.
Q81416970 P2093 Q81416970-F5443C77-CA74-4B96-89D0-459DE8986C8D @default.
Q81416970 P2093 Q81416970-F7BE26EB-D6BC-4EDC-AD8E-1D7D9CE67FCD @default.
Q81416970 P2860 Q81416970-095B9BC7-007F-4C9D-859F-63439A8DA436 @default.
Q81416970 P2860 Q81416970-1AF8FB48-3059-4E52-8FCF-EBA9A53E3B2F @default.
Q81416970 P2860 Q81416970-235456AD-D06D-44EE-B3A8-797E1B0EDF11 @default.
Q81416970 P2860 Q81416970-331F3E99-E392-41C6-8C0F-9FC97B0B5583 @default.
Q81416970 P2860 Q81416970-395CBB8A-29BF-4082-8477-E6C311DD2094 @default.
Q81416970 P2860 Q81416970-3CB1E811-D419-4B3F-9CA3-9E8BF22C65AF @default.
Q81416970 P2860 Q81416970-4F822298-7B3D-4FC8-9DAA-7448B14F64DE @default.
Q81416970 P2860 Q81416970-52ABAB5D-162C-4055-9951-CECE35968A7F @default.
Q81416970 P2860 Q81416970-5C3E1336-F94A-4EAF-A825-3CCAD3048AF7 @default.
Q81416970 P2860 Q81416970-65AF8585-3E07-4BA0-96A5-3B075EC48913 @default.
Q81416970 P2860 Q81416970-84D91E6A-F2D6-408A-893D-B2A2067FA480 @default.
Q81416970 P2860 Q81416970-861873EB-0202-476B-910C-EFD89D5E54D1 @default.
Q81416970 P2860 Q81416970-8CE2C02A-FB14-42C3-B938-6F42157AB6EA @default.
Q81416970 P2860 Q81416970-8DAED4C0-AAF0-472E-9EE9-A98DD8F26229 @default.
Q81416970 P2860 Q81416970-9714C5A0-8E8A-4AD0-B322-90FFC58D3BC4 @default.
Q81416970 P2860 Q81416970-9F13240B-2570-4EEF-80FD-A4D1AA9A799B @default.
Q81416970 P2860 Q81416970-B2ED8848-E969-4EDB-8070-6289095FC4DA @default.
Q81416970 P2860 Q81416970-BB1FD4C8-BD58-423C-B140-DFD36397EECA @default.
Q81416970 P2860 Q81416970-C3CC4AE8-919A-4183-95E6-99D8454D0FF4 @default.
Q81416970 P2860 Q81416970-C5A185BB-41F8-4B99-8106-135E8B6CEA74 @default.
Q81416970 P2860 Q81416970-DB3A866E-40D4-4166-86EA-425F70151618 @default.
Q81416970 P2860 Q81416970-DFF14C48-7856-407D-A705-CB7E02C3121F @default.
Q81416970 P2860 Q81416970-DFFD6955-F734-4158-815D-D25156AA08DC @default.
Q81416970 P2860 Q81416970-EB5630A6-FE09-46F6-9EAE-F641810E9EA6 @default.
Q81416970 P2860 Q81416970-FB552F68-6CC5-4C25-8D21-3EA1A7325848 @default.
Q81416970 P304 Q81416970-662C7A70-3AB7-43B0-99D5-58F831A9D4A2 @default.
Q81416970 P31 Q81416970-A912F22A-2FC8-4F3C-B4FC-E7BCD76BB05F @default.
Q81416970 P356 Q81416970-FB9B8D19-5618-49E4-8777-3EC073F72DF2 @default.
Q81416970 P433 Q81416970-D0DAA146-B25B-4C86-8C07-B35F7A389075 @default.
Q81416970 P478 Q81416970-9DFFCFBE-F8EB-483F-AB0B-E5CE7081E463 @default.
Q81416970 P577 Q81416970-B85AE802-49C5-4F1F-A8C1-F2DCE7B956A4 @default.
Q81416970 P698 Q81416970-49A33A27-186C-48B9-BE83-1DB83626B372 @default.
Q81416970 P921 Q81416970-97B99E98-984F-49F3-AF7A-76495B193EB3 @default.
Q81416970 P921 Q81416970-B84743AA-C0D2-44DA-ABF1-7129DBE5946C @default.
Q81416970 P921 Q81416970-C65E360A-9A02-4964-BC16-FB5C0F9F13DC @default.
Q81416970 P921 Q81416970-DEF613C1-D535-4168-961F-BDB94DFC5D21 @default.
Q81416970 P921 Q81416970-F01930AF-8669-4AF0-A7D5-4E31A4D5BFED @default.
Q81416970 P356 HED.20163 @default.
Q81416970 P698 15719391 @default.
Q81416970 P1433 Q13703062 @default.
Q81416970 P1476 "Toxicity and outcome analysis of patients with recurrent head and neck cancer treated with hyperfractionated split-course reirradiation and concurrent cisplatin and paclitaxel chemotherapy from two prospective phase I and II studies" @default.
Q81416970 P2093 "Corey J Langer" @default.
Q81416970 P2093 "Eric J Sherman" @default.
Q81416970 P2093 "Eric M Horwitz" @default.
Q81416970 P2093 "James S Babb" @default.
Q81416970 P2093 "Jason A Damsker" @default.
Q81416970 P2093 "John A Ridge" @default.
Q81416970 P2093 "Jonathan Cheng" @default.
Q81416970 P2093 "Nicos Nicolaou" @default.
Q81416970 P2093 "Noel M Kramer" @default.
Q81416970 P2093 "Roger B Cohen" @default.
Q81416970 P2093 "Steven J Feigenberg" @default.
Q81416970 P2860 Q25938997 @default.
Q81416970 P2860 Q33340024 @default.
Q81416970 P2860 Q33479117 @default.
Q81416970 P2860 Q36436894 @default.
Q81416970 P2860 Q40104994 @default.
Q81416970 P2860 Q41327924 @default.
Q81416970 P2860 Q44267907 @default.
Q81416970 P2860 Q44661695 @default.
Q81416970 P2860 Q44674194 @default.
Q81416970 P2860 Q45236091 @default.
Q81416970 P2860 Q54675183 @default.
Q81416970 P2860 Q56532851 @default.
Q81416970 P2860 Q67485777 @default.
Q81416970 P2860 Q67737002 @default.
Q81416970 P2860 Q68003591 @default.
Q81416970 P2860 Q69060413 @default.
Q81416970 P2860 Q69353324 @default.
Q81416970 P2860 Q69701287 @default.
Q81416970 P2860 Q70065218 @default.
Q81416970 P2860 Q70154473 @default.
Q81416970 P2860 Q71047640 @default.
Q81416970 P2860 Q71234146 @default.
Q81416970 P2860 Q71657333 @default.